MoneyWorks4Me

Zydus Animal Health Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Zydus Animal-Amalgam Share Price

BSE Share Price
Not Listed

Zydus Animal Health Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Zydus Animal-Amalgam Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.2
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
16.09%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
₹0 Cr.
Face Value
₹10
All Time Low / High
- / -

Zydus Animal Health . - (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'09Mar'10Mar'11Mar'12TTM
ROCE % 34%59.5%110.6%89.8%-

Growth Parameters

Sales 107116137159159
Sales YoY Gr.-8.9%17.5%16.1%-
Adj EPS 3.26.998.70
YoY Gr.-117.8%31.2%-3.1%-
BVPS (₹) 10.311.813.915.60
Adj Net
Profit
1716.521.620.90
Cash Flow from Ops. 22.618.917.616.2-
Debt/CF from Ops. 0000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA14.1%16.1%
Adj EPS NANA40.4%-3.1%
BVPSNANA15.1%12.6%
Share Price - - - -

Key Financial Parameters

Mar'09Mar'10Mar'11Mar'12TTM
Return on
Equity %
30.739.37059.20
Op. Profit
Mgn %
25.324.824.219.5NAN
Net Profit
Mgn %
15.914.115.813.20
Debt to
Equity
0000-
Working Cap
Days
01011011000
Cash Conv.
Cycle
02214350

Valuation of Zydus Animal-Amalgam - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zydus Animal Health Ltd. - (Amalgamated) FAQs

The current trading price of Zydus Animal-Amalgam on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zydus Animal-Amalgam stood at ₹0.00 Cr

The latest P/E ratio of Zydus Animal-Amalgam as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Zydus Animal-Amalgam as of 31-Dec-1969 is 0.00.

The 52-week high of Zydus Animal-Amalgam is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Animal-Amalgam is ₹159 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Zydus Animal Health Ltd. - (Amalgamated)

No data to display
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now